Accordingly, the oncogenic activity of fusion gene TCF3-PBX1 in pre-B ALL in blocking B-cell differentiation may be related to physiological downregulation of PBX1 in B-cell development [40,43]. This evidence concerns the gene TCF3 and acute lymphoblastic leukemia.